register now
get brochure
add event to diary
call back
contact us
Contact

conference details
Congress Day One
6 December 2009
 
Congress Day Two
7 December 2009
 
Congress Day Three
8 December 2009

register for a brochure
add this to my calendar

Register online now 
or call +44 (0)20 7242 2324

recommended reading

 
World Influenza Congress Europe is the annual vaccine conference for influenza candidate COMMERCIALISATION, REVENUE GENERATION AND MARKET SUPPLY. It also highlights policy and planning, influenza research & development, and stakeholder partnerships. 
 
INFLUENZA VACCINE COMMERCIALISATION

As an addition to an already globally recognised World Vaccine Congress series, World Influenza Congress Europe is positioned as Europe's largest and most influential Influenza vaccine COMMERCIALISATION event.

» request a sponsorship prospectus 

2009 POST SHOW REPORT

Following the 2009 congress we have produced a post show report to give a brief overview of the event, the speakers, the attendees and what we have planned for 2010. It can be downloaded as a pdf.

» download the post show report

SPONSOR NOW FOR BEST RETURNS
 
The World Flu Congress Europe is where the World's pharmaceutical and biotech companies come to find solutions and ideas. If you are in the business of providing world-class solutions you need to be here. 
  • The Congress is a marketing solution that generates new business 
  • The Congress is attended by decision makers
  • The Congress is an unrivalled and cost-effective sales and profile solution
WHO SHOULD SPONSOR?
  • Contract Manufacture Organisations
  • Contract Research Organisations
  • Equipment Providers and Manufacturers
  • Delivery Technology Manufacturers
  • Vaccine Manufacturers and Biotechs
  • Vaccine Technology Platforms
  • Clinical Research Sites / Laboratories
  • Consultants
  • Law Firms
  • Venture Capital / Investment Banks
To discuss in detail your requirements and the show call Gaurav Koul on +44 (0) 207 092 1233 or email gaurav.koul@terrapinn.com
 
 
meet new partners
 
1-2-1 PARTNERING

Opportunities with "Contact" - Schedule dedicated onsite meetings with partners and gain the visibility your company needs.
 
» networking opportunities 
 

designed for networking 
 
KEY REASONS TO ATTEND
  • The World’s largest influenza and antivirals vaccine congress addressing global pandemic trends and key regulatory and industry response 
     
  • Over 45 sessions covering strategic pandemic influenza preparedness and response with unique industry showcases
     
  • Unrivalled global participation from regulators, pharma and biotech with every key player in the influenza market participating 
  2009 SPEAKERS INCLUDED
 
DR ROBIN ROBINSON
Director, BARDA and ASPR Assistant Deputy Secretary
US Department of Health and Human Services
 
DR EMMANUEL HANON
Vice President, Influenza Vaccine Franchise
GSK Biologicals
 
DR NATHALIE GARÇON
Vice President, Head of Research and North America R&D
GSK Biologicals
 
DR JAMES ROBERTSON
Principal Scientist, Division of Virology
National Institute for Biologicals Standards and Control
 
DR RAHUL SINGHVI
Chief Executive Officer
Novavax
  
DR THOMAS MUSTER
Chief Executive Officer and Chief Scientific Officer
AVIR Green Hills Biotechnology
 
DR VIDADI YUSIBOV
Executive Director
Fraunhofer USA
 
 


 
 
DR KLAUS STÖHR
Vice President, Global Head, Influenza Strategy Liaison
Novartis Vaccines and Diagnostics
 
DR DEREK O'HAGAN
Vice President and Head of Vaccine Delivery Research
Novartis Vaccines & Diagnostics
 
DR GREGORY GLENN
Chief Scientific Officer
Intercell USA
 
DR JAAP GOUDSMIT
Chief Scientific Officer
Crucell
 
DR LYNDA TUSSEY
Vice President, Research & Development
VaxInnate
 
DR MARTIN BACHMANN
Chief Scientific Officer
Cytos Biotechnology
   
DR THOMAS STAUFFER
Chief Executive Officer
Pevion Biotech
 
DR MILES CARROLL
Deputy Director, Research
Health Protection Agency
 
 
DR IGOR KRASILNIKOV
Chief, Research and Development
Microgen
 
 
DANIEL ADAMS
Chief Executive Officer
Protein Sciences
 
DR JAMES BAKER
Chief Executive Officer
NanoBio Corporation
 
 
PAUL RADSPINNER
Chief Executive Officer
FluGen 
 
 
DR JOHN HANRAHAN
Chief Medical Officer
Pulmatrix 
 
 
DR SAMUEL BOGOCH
Chairman
Replikins 
 
DR BRAM PALACHE
Global Scientific Communication and Public Affairs Director for Influenza Vaccines
Solvay Biologicals
and Co-Chair Influenza Working Group
European Vaccine Manufacturers 
 
 
 
 
 
 
 
 

 
 
2009 sponsors
 
 
 
from the same team as
 
 
 
 

sponsorship opportunities
Sponsoring the World Influenza Congress will give you access to our marketing expertise. Let us raise your international and regional profile.
 
What we can provide sponsors with:
 
Branding and positioning – being seen as an industry leader in this space. 
 
Lead generation – meeting new prospects in a cost and time effective manner. 
 
Establishing credibility for your product or service by delivering a strong commercial message and making your business case. 
 
Creating awareness, raising your profile and getting your brand, product or service front of mind with key decision makers in this space 
 
Demonstrating your credibility with a market that knows you well through efficient and effective networking that facilitates new business and puts your company on preferred supplier lists and procurement shortlists
 
 
 
Target your market!
 
For details contact
Gaurav Koul


Leave a comment | Contact Us | About Terrapinn | Site map | Privacy | T&Cs ©Terrapinn Holdings Ltd. MMX